Stakeholder group | Mexico | Switzerland | Germany | UK | Total |
---|---|---|---|---|---|
Regulations for market approval | |||||
Group 1 | - | +++ | +++ | +++ | ++(+) |
Group 2 | - | ++ | ++ | +++ | +(+) |
Group 3 | ++ | +++ | +++ | +++ | ++(+) |
Group 4 | ++ | +++ | +++ | +++ | ++(+) |
Total | + | ++(+) | ++(+) | +++ | |
Regulations for eligibility | |||||
Group 1 | + | ++ | +++ | +++ | ++(+) |
Group 2 | - | +++ | ++ | ++ | +(+) |
Group 3 | ++ | +++ | +++ | +++ | ++(+) |
Group 4 | ++ | ++ | +++ | +++ | ++ |
Total | + | ++ | ++(+) | ++(+) | |
Procurement regulations and practices | |||||
Group 1 | ++ | - | - | - | (+) |
Group 2 | - | - | - | - | - |
Group 3 | +++ | - | + | - | + |
Group 4 | +++ | - | + | - | + |
Total | ++ | - | (+) | - | |
Programmes targeting quality and supporting procurement | |||||
Group 1 | + | - | - | - | (+) |
Group 2 | + | - | - | - | (+) |
Group 3 | ++ | - | - | - | (+) |
Group 4 | ++ | - | - | - | (+) |
Total | +(+) | - | - | - | |
Factors influencing procurement | |||||
Cost | +++ | - | + | - | + |
Knowledge | +++ | - | + | - | + |
Clinical evidence | +++ | - | - | - | + |
Procurement setting | +++ | - | - | - | + |
Total | +++ | - | (+) | - |